Emerald Mutual Fund Advisers Trust’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$48M Sell
519,545
-4,387
-0.8% -$440K 2.33% 3
2025
Q4
$53.5M Sell
523,932
-32,077
-6% -$2.87M 2.61% 2
2025
Q3
$34.7M Buy
556,009
+140,235
+34% +$7.63M 1.79% 8
2025
Q2
$21.6M Buy
415,774
+88,491
+27% +$3.95M 1.32% 21
2025
Q1
$13.9M Buy
+327,283
New +$14.1M 0.99% 37

Other funds holding GH

Emerald Mutual Fund Advisers Trust's GH Position: Q1 2026 in Review

Emerald Mutual Fund Advisers Trust reduced its Guardant Health (GH) stake by 0.84% in Q1 2026, selling an estimated $440K and leaving 519,545 shares worth $48M. The position accounts for 2.33% of the portfolio, ranked #3.

Emerald Mutual Fund Advisers Trust first reported a position in GH in Q1 2025 and has held it in 5 quarters since. The position peaked at $53.5M in Q4 2025. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Emerald Mutual Fund Advisers Trust held 519,545 shares of Guardant Health worth $48M as of Q1 2026.
  • Emerald Mutual Fund Advisers Trust sold 4,387 Guardant Health shares in Q1 2026, an estimated $440K.
  • Guardant Health made up 2.33% of Emerald Mutual Fund Advisers Trust's portfolio in Q1 2026, its #3 holding.
  • Emerald Mutual Fund Advisers Trust first reported a position in Guardant Health in Q1 2025 and has held it in 5 quarters since.
  • Emerald Mutual Fund Advisers Trust's Guardant Health position peaked at $53.5M in Q4 2025.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q1 2026, filed 4 May 2026.